Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

Chelsea X Alvarado | D. Hernandez | M. Nalls | A. Singleton | J. Hoenicka | J. Jankovic | H. Leonard | D. Vitale | H. Iwaki | C. Blauwendraat | F. Faghri | O. Monchi | A. Kishore | M. I. Norlinah | J. Shulman | R. Krüger | R. Akinyemi | E. Disbrow | M. Stamelou | T. Foroud | K. Lohmann | K. Kieburtz | Sohini Chowdhury | B. Mollenhauer | T. Sherer | N. Hattori | R. Weil | L. Parnetti | A. Brice | P. Pástor | Julie Hunter | P. Chan | J. Corvol | Honglei Chen | M. Rentería | S. Dumanis | T. Gasser | E. Valente | S. Bardien | H. Morris | A. Espay | N. Ibrahim | S. Kõks | B. Tang | R. Gouider | T. Pitcher | H. Houlden | Ji-feng Guo | S. Lubbe | P. Pal | I. Tarnanas | E. Shamim | G. Xiromerisiou | L. Stefanis | M. Avenali | P. Lewis | S. Bandres-Ciga | D. Martinez-Ramirez | A. Akpalu | F. Sarfo | R. Borgohain | C. Shepherd | B. Fiske | L. Norcliffe-Kaufmann | R. Rajan | I. Kacem | N. Mencacci | L. Shulman | A. Noyce | R. Wu | Marissa Dean | Álvaro Hernández | B. Casey | S. Stott | Gharib Fawi | Y. Kim | J. Carr | B. Jeon | L. Chahine | J. Aasly | M. Miranda | W. Luo | A. Viñuela | M. Funayama | A. Zimprich | V. Tumas | L. Marsili | A. Quattrone | G. Höglinger | J. Hardy | K. Wahab | K. Mok | R. Akinyemi | E. Fon | Hsiu-Chuan Wu | J. Foo | A. Başak | A. Ahmad-Annuar | Shen-Yang Lim | K. Heilbron | M. Kauffman | L. Nfor | X. Reed | E. Vollstedt | N. Williams | N. Tayebi | Jared N Williamson | Y. Maiga | Z. Fang | M. Ellis | G. Arboleda | A. Singleton | G. Chan | Nelson Yuk-Fai Cheung | C. Pantazis | Chin-Hsien Lin | C. Erameh | M. Atadzhanov | N. Okubadejo | O. Ojo | O. Oshinaike | Xiaopu Zhou | Tao Xie | Jamie Toms | R. Ojha | S. Mrabet | R. Alcalay | T. Schirinzi | Sumit Dey | O. Okunoye | S. Balarabe | S. Azmin | K. Nuytemans | M. Rizig | C. Bale | L. Pihlstrøm | Yeajin Song | G. Modi | Jillian H. Kluss | A. Schumacher-Schuh | I. Dagklis | P. Adjei | Mohamed Salama | P. Adebayo | A. Shalash | Lakshay Malik | S. Ertan | N. Okubadejo | C. Guinto | R. Kaiyrzhanov | F. Taiwo | Laurel A. Screven | Biniyam Alemayehu Ayele | D. G. Massi | S. El-sadig | A. Charway-Felli | K. Divya | Christine Klein | M. J. Rio | Andrew K. Sobering | Y. Zewde | A. Mengesha | T. Farombi | G. Osaigbovo | M. Komolafe | M. Fawale | Y. Obiabo | M. Fall | S. El-Jaafary | A. Mochan | A. Nasri | A. Gargouri | N. Wood | S. Wu | N. Osemwegie | M. Cornejo-Olivas | F. Ojini | P. Nwani | R. Amouri | Wael M. Y. Mohamed | W. Kamel | L. Chishimba | V. Obese | S. Abubakar | Inas Elsayed | I. Sghaier | Özgür Çakmak | Babawale Arabambi | E. Nwazor | M. Djebara | T. Shiraishi | A. Adebowale | O. Agabi | Claire E. Wegel | Jorge Orozco | K. Daida | J. J. Kim | Leonard Msango | F. Odiase | Toan Nguyen | T. Anderson | Pin-Jui Kung | P. Reyes-Pérez | J. Junker | Dan Vitale | Pilar Alvarez Jerez | A. Bello | U. Williams | Deborah Hall | Alex Medina | P. Kukkle | Harutyun Madoev | Jillian H Kluss | E. Iwuozo | O. Ekenze | P. Chaná | Sarah Misbah | G. Onwuegbuzie | M. A. Awadelkareem | Z. Tavadyan | Imen Mkada | D. Standaert | B. Siddiqi | M. Padmanaban | G. Genc | Bahafta Berhe | G. Kaishibayeva | A. Karimova | Eman M. Khedr | Naomi Louie | J. Kim | Yannick Fogang Fogoum | Kimberley J. Billingsley | M. Rosenbaum | Johanna Junker | E. A. Awadelkareem | Muhammad Umair | C. Wegel | F. Otubogun | D. M. Oda | F. Jama | A. Bocoum | F. Imarhiagbe | S. Sassi | Samson Khachatryan | A. Illarionova | Mohammed W Ali | H. Kimambo | Lara M. Lange | N. Ip | C. Carroll | Kehinde Abiodun | J. Solle | E. Gatto | Arinola O Sanyaolu | Abdourhamane Koita | H. Madoev | Yi-Heng Wu | I. Sarmiento | M. Sharma | Pauly Awad | Maha Dahawi | Bashayer Al Mubarak | T. Beach | Y. Nyandaiti | M. Bustamante | Cabell Jonas | L. Lange | P. Çakmak | Kyle Rizer | Ignacio F. Mata | A. Diop | Lauren Ruffrage | Kristin S. Levine | K. Marek | Alejandro Martinez-Carrasco | Katelyn T. Lofton | Mélanie Annick Magnerou | T. Coulibaly | K.C. Murphy | Olaleye A. Adeniji | O. Arigbodi | S. Oyakhire | I. Ani-Osheku | Olanike Odeniyi | Oladunni Abiodun | Y. Zubair | K. Kumar | Uc Agulanna | Simon Ozomma | Sarah Urassa | C. Achoru | M. B. Makarious | M. Eltantawi | C. Alvarado | Kristin S Levine | S. Dindayal | E. G. B. Lamou | Mathew J Koretsky | Peter Wild Crea | Sani Abubakar | Abigail Miano-Burkhardt | Ellen Sidranksy | S. Samuel | Alyssa N. O’Grady | M. Rodríguez‐Violante | S. Davis | Andrea M D'Souza | N. A. Murad | M. Nalls | E. Iakovenko | C. Rieder | M. Tan | J. Smith | M. Ali | Breeana Baker | Olajumoke Olufemi Oshinaike | Sarah Chabiri Samuel | Hassan El-FawaI | Sharifa Hamed | Yohanesse Debebe Gelan | Albert AkpaIu | Z. Kone | Abiodun Bell | John E Akpekpe | Alagoma lyagba | Ali Mohammed Wulgo | C. Agu | F. Dike | I. Ishola | Paul Agabi Osigwe | Ewodo Touna Hilaire Dominique | Brighton Mushengez | Kigocha OKeng | Marieke Diekker | Candace Cromer | Joseph Richardson | Rebeka Sipma | Manesh Padmanaban | Natalie Warren | Tomas Mercado | Brian Chauppeta | Fermine Thomas-Dean | Ashley E. Rawls | Nieci Black | Ai-Huey Tan | Benjamin Pizarro Galleguillos | Charisse Comart | D. Nguyen | Efthymios Dadiotis | E. Riley | E. Stafford | Georgios Hadjigorgiou | Hu Shang | Maggie Kuhl | Maria Teresa Periñan Tocino | Miguel z Inca-Martines | Phillip Chan | Sergio Groppa | S. Ur-Rehman | Simona Jasaitye | Te-Chih Fon | Yi-Chien Wen | Karen Nuytemans | Ignacio F Mata | Mario R Cornejo-Olivas | Ashley E Rawls | Bradford Casey | Emilia M. Gatto | S. El-Sadig | Tim J. Anderson | P. Pastor | Albert Akpalu | Paula Reyes-Pérez | Lorraine Chishimba | Augustina Charway-Felli | Y. Fogoum | M. Makarious | Temitope Farombi | Bahafta A. Berhe | Olajumoke Oshinaike | M. Magnerou | Kigocha Okeng | M. T. P. Tocino | Muhammad Umair

[1]  Kevin L. Keys,et al.  Gene expression in African Americans, Puerto Ricans and Mexican Americans reveals ancestry-specific patterns of genetic architecture , 2023, Nature Genetics.

[2]  D. Hernandez,et al.  MAPT allele and haplotype frequencies in Nigerian Africans: population distribution and association with Parkinson’s disease risk and age at onset , 2023, medRxiv.

[3]  C. Blauwendraat,et al.  The annotation and function of the Parkinson’s and Gaucher disease-linked gene GBA1 has been concealed by its protein-coding pseudogene GBAP1 , 2023, bioRxiv.

[4]  Sonja W. Scholz,et al.  Genetic risk factor clustering within and across neurodegenerative diseases , 2022, medRxiv.

[5]  D. Hernandez,et al.  APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease , 2022, npj Parkinson's Disease.

[6]  M. Nalls,et al.  Multi-ancestry genome-wide meta-analysis in Parkinson's disease , 2022, medRxiv.

[7]  Sonja W. Scholz,et al.  Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA gene , 2022, Communications Biology.

[8]  Z. Wszolek,et al.  Screening of GBA Mutations in Nigerian Patients with Parkinson's Disease , 2021, Movement disorders : official journal of the Movement Disorder Society.

[9]  T. Thornton,et al.  Characterizing the Genetic Architecture of Parkinson's Disease in Latinos , 2020, medRxiv.

[10]  Anisah W. Ghoorah,et al.  High-depth African genomes inform human migration and health , 2020, Nature.

[11]  M. Nalls,et al.  Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study. , 2020, JAMA neurology.

[12]  Andrew B Singleton,et al.  The genetic architecture of Parkinson's disease , 2020, The Lancet Neurology.

[13]  S. Bardien,et al.  Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's disease , 2019, Neurobiology of Aging.

[14]  Sonja W. Scholz,et al.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies , 2019, The Lancet Neurology.

[15]  H. Houlden,et al.  Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease , 2018, bioRxiv.

[16]  A. Brice,et al.  Mutation Analysis of Consanguineous Moroccan Patients with Parkinson’s Disease Combining Microarray and Gene Panel , 2017, Front. Neurol..

[17]  Sonja W. Scholz,et al.  NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases , 2017, Neurobiology of Aging.

[18]  C. Adler,et al.  The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease. , 2017, Biomarkers in medicine.

[19]  T. Foroud,et al.  DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study , 2016, The Lancet Neurology.

[20]  B. Oostra,et al.  Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease. , 2012, Parkinsonism & related disorders.

[21]  M. Amboni,et al.  Screening LRRK2 gene mutations in patients with Parkinson’s disease in Ghana , 2012, Journal of Neurology.

[22]  Marwa A. Saad,et al.  G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease. , 2011, Genetic testing and molecular biomarkers.

[23]  John Hardy,et al.  A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci. , 2011, Human molecular genetics.

[24]  M. Farrer,et al.  LRRK2 variation and Parkinson's disease in African Americans , 2010, Movement disorders : official journal of the Movement Disorder Society.

[25]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[26]  S. Bardien,et al.  Analysis of exon dosage using MLPA in South African Parkinson's disease patients , 2010, neurogenetics.

[27]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[28]  S. Bardien,et al.  Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease. , 2009, Parkinsonism & related disorders.

[29]  A. Singleton,et al.  Analysis of Nigerians with Apparently Sporadic Parkinson Disease for Mutations in LRRK2, PRKN and ATXN3 , 2008, PloS one.

[30]  P. Matthews,et al.  PINK1 mutations and parkinsonism , 2008, Neurology.

[31]  P. Matthews,et al.  LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study , 2008, The Lancet Neurology.

[32]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[33]  K. Marder,et al.  The Saitohin ‘Q7R’ polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts , 2003, Neuroscience Letters.

[34]  J. K. Park,et al.  Glucocerebrosidase mutations among African-American patients with type 1 Gaucher disease. , 2001, American journal of medical genetics.

[35]  M. Farrer,et al.  Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family. , 2001, Archives of neurology.

[36]  E. Sidransky,et al.  Gene rearrangement on 1q21 introducing a duplication of the glucocerebrosidase pseudogene and a metaxin fusion gene , 2000, Human Genetics.

[37]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[38]  S. Peters,et al.  A microassay for Gaucher's disease. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[39]  M. Farrer,et al.  Glucocerebrosidase mutations in diffuse Lewy body disease. , 2011, Parkinsonism & related disorders.